A Curated Platform of Equity & Options Market Intelligence
Select Page

GOSS

Search by
TICKER SYMBOL

Gossamer Bio Inc

Sector: Manufacturing
Industry: Pharmaceutical Products

0.88

-0.01

(-1.22%)

Volume:

919,678

52 week range:

0.49 - 1.60

Market Cap:

200.998M

Company Description:

Gossamer Bio, Inc. focuses on discovering, acquiring, developing, and commercializing therapeutics in immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor. GB5121, an oral, irreversible, covalent, small. molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central. central central nervous system lymphoma.